References
- Thokala P . Multiple criteria decision analysis for health technology assessment. Report by the Decision Support Unit. 2011; Sheffield, UK: University of Sheffield.
- Walker S , Phillips L , Cone M . Benefit risk assessment model for medicines: Developing a structured approach to decision making. 2006; Epsom: Center for Medicines Research International, Institute for Regulatory Science.
- Mussen F , Salek S , Walker S . A quantitative approach to benefit-risk assessment of medicines – Part 1: The development of a new model using multi-criteria decision analysis. Pharmacoepidemiol Drug Saf. 2007; 16: S2–S15. [PubMed Abstract].
- Sussex J , Towse A , Devlin N . Operationalizing value-based pricing of medicines: A taxonomy of approaches. Pharmacoeconomics. 2013; 31: 1–10. [PubMed Abstract].
- Giove S , Rosato P , Breil M . An application of multicriteria decision making to built heritage. The redevelopment of Venice Arsenale. J Multi Criteria Decis Anal. 2010; 17: 85–99.
- Linkov I , Stevens J . Hudnell HK . Multi-criteria decision analysis (Chapter 35, Appendix A). Cyanobacterial harmful algal blooms: State of the science and research needs. 2008; New York: Springer Science+Business Media, LLC. 815–29. Advances in experimental medicine and biology. Vol. 619.
- Tony MM , Wagner M , Khoury H , Rindress D , Papastravos T , Oh P et al. . Bridging health technology assessment (HTA) with multicriteria decision analysis (MCDA): Field testing of the EVIDEM framework for coverage decisions by a public payer in Canada. BMC Health Serv Res. 2011; 11: 329. [PubMed Abstract] [PubMed CentralFull Text].
- Department for Communities and Local Government. Multi-criteria analysis: A manual. 2009. Available from: http://eprints.lse.ac.uk/12761/1/Multi-criteria_Analysis.pdf [cited 12 June 2014].
- Thokala P , Duenas A . Multiple criteria decision analysis for health technology assessment. Value Health. 2012; 15: 1172–81. [PubMed Abstract].
- Rotter JS , Foerster D , Bridges JF . The changing role of economic evaluation in valuing medical technologies. Expert Rev Pharmacoecon Outcomes Res. 2012; 12: 711–23. [PubMed Abstract].
- Poulin P , Austen L , Scott CM , Waddell CD , Dixon E , Poulin M et al. . Multi-criteria development and incorporation into decision tools for health technology adoption. J Health Organ Manag. 2013; 27: 246–65. [PubMed Abstract].
- Dodgson JS , Spackman M , Pearman A , Phillips LD . Multi-criteria analysis: A manual. 2009; London: Department for Communities and Local Government.
- Antoñanzas F , Olivia J , Pinillos M , Juarez C . Economic aspects of the new Spanish law on pharmaceutical preparations. Eur J Health Econ. 2007; 8: 297–300.
- Garattini L , Cornago D , De Compadri P . Pricing and reimbursement of in-patient drugs in seven European countries: A comparative analysis. Health Policy. 2007; 82: 330–9. [PubMed Abstract].
- Devlin N , Parkin D . Does NICE have a cost-effectiveness threshold and what other factors influence its decisions?. A binary choice analysis. Health Econ. 2004; 13: 437–52.
- Harris AH , Hill SR , Chin G , Li JJ , Walkom E . The role of value for money in public insurance coverage decisions for drugs in Australia: A retrospective analysis 1994–2004. Med Decis Making. 2008; 28: 713–22. [PubMed Abstract].
- Pezzullo JC , Sullivan KM . Logistic regression. Available from: http://statpages.org/logistic.html [cited 6 September 2014].